Safety of submacular suprachoroidal drug administration via a microcatheter: Retrospective analysis of European treatment results

Ophthalmologica

Volumn 227, Issue 4, 2012, Pages 183-189

  Tetz, Manfred ^a   Rizzo, Stanislao ^c   Augustin, Albert J ^b  

^a Berlin Eye Research Institute   (Germany)

^b Klinikum Karlsruhe   (Germany)

^c Azienda Ospedaliera   (Italy)

Author keywords

Age related macular degeneration; Drug administration, submacular suprachoroidal; Microcatheter

Indexed keywords

BEVACIZUMAB; PEGAPTANIB; RANIBIZUMAB; TRIAMCINOLONE ACETONIDE; VERTEPORFIN;

ADULT; AGED; ARTICLE; CATARACT; CATHETERIZATION; CHOROID HEMORRHAGE; CLINICAL ARTICLE; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG SAFETY; EUROPE; FEASIBILITY STUDY; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; SIDE EFFECT; SUBMACULAR SUPRACHOROIDAL DRUG ADMINISTRATION; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CATHETERS, INDWELLING; CHOROID; DRUG DELIVERY SYSTEMS; DRUG THERAPY, COMBINATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84860452674     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000336045     Document Type: Article

References (16)

1. Macular Photocoagulation Study Group: Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Arch Ophthalmol 1991; 109: 1109-1114.
2. Lommatzsch AP, Heimes B, Gutfleisch M, Spital G, Zeimer M, Pauleikhoff D: Treatment of vascularised serous pigment epithelium detachment in AMD -observations after changing the intravitreal agent due to lack of response. Klin Monatsbl Augenheilkd 2008; 225: 874-879.
3. Nigam N, Hedava J, Freeman WR: Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions. Br J Ophthalmol 2008; 92: 864-865.
4. Azad R, Chandra P, Gupta R: The economic implications of the use of anti-vascular endothelial growth factor drugs in age-related macular degeneration. Indian J Ophthalmol 2007; 55: 441-443.
5. Artunay O, Yuzbasioglu E, Rasier R, Sengül A, Bahcecioglu H: Incidence and management of acute endophthalmitis after intravitreal bevacizumab (Avastin) injection. Eye 2009; 23: 2187-2193.
6. Wu L, Martínez-Castellanos MA, Quiroz-Mercado H, Arevalo JF, Berrocal MH, Farah ME, Maia M, Roca JA, Rodriguez FJ, Pan American Collaborative Retina Group: Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol 2008; 246: 81-87.
7. Angulo Bocco MC, Glacet-Bernard A, Zourdani A, Coscas G, Soubrane G: Intravitreous injection: retrospective study on 2,028 injections and their side effects. J Fr Ophtalmol 2008; 31: 693-698.
8. Einmahl S, Savoldelli M, D'Hermies F, Tabatabay C, Gurny R, Behar-Cohen F: Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye. Invest Ophthalmol Vis Sci 2002; 43: 1533-1539.
9. Olsen TW, Feng X, Wabner K, Conston SR, Sierra DH, Folden DV, Smith ME, Cameron JD: Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment. Am J Ophthalmol 2006; 142: 777-787.
10. Zhu Q, Ziemssen F, Henke-Fahle S, Tatar O, Szurman P, Aisenbrey S, Schneiderhan-Marra N, Xu X, Tübingen Bevacizumab Study Group, Grisanti S: Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization. Ophthalmology 2008; 115: 1750-1755.
11. Beer PM, Bakri SJ, Singh RJ, Liu W, Peters GB 3rd, Miller M: Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 2003; 110: 681-686.
12. Wu L, Arevalo JF, Berrocal MH, Maia M, Roca JA, Morales-Cantón V, Alezzandrini AA, Díaz-Llopis MJ: Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the Pan American Collaborative Retina Study Group at 24 months. Retina 2010; 30: 1002-1011.
13. Lewis RA, von Wolff K, Tetz M, Koerber N, Kearney JR, Shingleton B, Samuelson TW: Canaloplasty: circumferential viscodilation and tensioning of Schlemm's canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults: interim clinical study analysis. J Cataract Refract Surg 2007; 33: 1217-1226.
14. Lewis RA, von Wolff K, Tetz M, Koerber N, Kearney JR, Shingleton B, Samuelson TW: Canaloplasty: circumferential viscodilation and tensioning of Schlemm canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults: two-year interim clinical study results. J Cataract Refract Surg 2009; 35: 814-824.
15. Lewis RA, von Wolff K, Tetz M, Koerber N, Kearney JR, Shingleton BJ, Samuelson TW: Canaloplasty: Three-year results of circumferential viscodilation and tensioning of Schlemm canal using a microcatheter to treat open-angle glaucoma. J Cataract Refract Surg 2011; 37: 682-690.
16. Guyer D, Schachat A, Green R: The choroid: structural considerations; in Ryan S (ed): Retina, ed 4. St. Louis, Mosby, 2006, pp 33-42.